Michael R Lebens

Title: Michael R Lebens: Innovator in Somatotropin Analogues

Introduction

Michael R Lebens is a notable inventor based in Gotenberg, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of somatotropin analogues. His work focuses on enhancing the stability and biological activity of these important proteins.

Latest Patents

Michael R Lebens holds a patent for "Somatotropins with alterations in the alpha-helix 1 region." This invention relates to somatotropin analogues that feature amino acid changes in the alpha-helix 1 regions. These analogues can be used alone or in combination with mutations in the alpha-helix 2 and 3 regions. The resulting products are stable for formulation in sustained release applications while maintaining their biological activity. Additionally, the patent provides methods for conducting site-directed mutagenesis on DNA encoding proteins and/or polypeptides.

Career Highlights

Throughout his career, Michael has worked with prominent companies in the biotechnology sector. He has been associated with Bio-Technology General Corporation and American Cyanamid Company, where he contributed to various innovative projects. His expertise in protein engineering has been instrumental in advancing the field.

Collaborations

Michael has collaborated with notable professionals in his field, including Meir Fischer and Deborah Tardy Chaleff. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Michael R Lebens is a distinguished inventor whose work on somatotropin analogues has made a significant impact in biotechnology. His innovative approaches continue to influence the development of stable and effective protein formulations.